Peder Buchhave

3.6k total citations · 2 hit papers
13 papers, 2.8k citations indexed

About

Peder Buchhave is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Peder Buchhave has authored 13 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 12 papers in Psychiatry and Mental health and 3 papers in Neurology. Recurrent topics in Peder Buchhave's work include Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (12 papers) and Functional Brain Connectivity Studies (2 papers). Peder Buchhave is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (12 papers) and Functional Brain Connectivity Studies (2 papers). Peder Buchhave collaborates with scholars based in Sweden, United States and Germany. Peder Buchhave's co-authors include Oskar Hansson, Lennart Minthon, Kaj Blennow, Henrik Zetterberg, Elisabet Londos, Sabina Janciauskiene, Ulf Andréasson, Henrietta M. Nielsen, Guoxin Wu and Sethu Sankaranarayanan and has published in prestigious journals such as PLoS ONE, The Lancet Neurology and Obstetrics and Gynecology.

In The Last Decade

Peder Buchhave

13 papers receiving 2.7k citations

Hit Papers

Association between CSF biomarkers and incipient Alzheime... 2006 2026 2012 2019 2006 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
    2006 1.3k citations Oskar Hansson, Henrik Zetterberg et al. The Lancet Neurology profile →
  2. Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
    2012 502 citations Peder Buchhave Archives of General Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peder Buchhave Sweden 12 2.1k 1.5k 726 639 302 13 2.8k
Xiyun Chai United States 8 1.9k 0.9× 1.2k 0.8× 611 0.8× 563 0.9× 218 0.7× 12 2.4k
Udo Eichenlaub Germany 14 2.0k 0.9× 1.8k 1.1× 588 0.8× 517 0.8× 366 1.2× 32 2.8k
Tobias Bittner Switzerland 26 2.5k 1.2× 1.6k 1.0× 1.0k 1.4× 882 1.4× 341 1.1× 56 3.8k
Andréa Lessa Benedet Canada 30 1.8k 0.9× 1.4k 0.9× 519 0.7× 497 0.8× 449 1.5× 101 2.7k
Ronald S. Black United States 22 2.4k 1.1× 1.1k 0.7× 715 1.0× 609 1.0× 316 1.0× 46 3.3k
Niki S.M. Schoonenboom Netherlands 22 1.3k 0.6× 1.0k 0.7× 530 0.7× 435 0.7× 195 0.6× 37 2.1k
M Orantes Germany 4 1.9k 0.9× 1.0k 0.6× 673 0.9× 580 0.9× 396 1.3× 4 2.7k
Tero Tapiola Finland 22 1.4k 0.7× 956 0.6× 432 0.6× 712 1.1× 293 1.0× 33 2.4k
Daniel J. Kerkman United States 20 1.6k 0.8× 1.2k 0.8× 445 0.6× 771 1.2× 287 1.0× 43 2.4k
Vitaliy Ovod United States 19 2.9k 1.4× 1.5k 0.9× 950 1.3× 940 1.5× 485 1.6× 26 4.2k

Countries citing papers authored by Peder Buchhave

Since Specialization
Citations

This map shows the geographic impact of Peder Buchhave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peder Buchhave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peder Buchhave more than expected).

Fields of papers citing papers by Peder Buchhave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peder Buchhave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peder Buchhave. The network helps show where Peder Buchhave may publish in the future.

Co-authorship network of co-authors of Peder Buchhave

This figure shows the co-authorship network connecting the top 25 collaborators of Peder Buchhave. A scholar is included among the top collaborators of Peder Buchhave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peder Buchhave. Peder Buchhave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Buchhave, Peder, et al.. (2012). CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease. PLoS ONE. 7(1). e30525–e30525. 208 indexed citations
2.
Buchhave, Peder. (2012). Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia. Archives of General Psychiatry. 69(1). 98–98. 502 indexed citations breakdown →
3.
Portelius, Erik, Ulf Andréasson, John M. Ringman, et al.. (2010). Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease. Molecular Neurodegeneration. 5(1). 2–2. 76 indexed citations
4.
Buchhave, Peder, Kaj Blennow, Henrik Zetterberg, et al.. (2009). Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease. PLoS ONE. 4(7). e6294–e6294. 74 indexed citations
5.
Buchhave, Peder, Erik Stomrud, Siegbert Warkentin, et al.. (2008). Cube Copying Test in Combination with rCBF or CSF Aβ<sub>42</sub>Predicts Development of Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 25(6). 544–552. 19 indexed citations
6.
Zetterberg, Henrik, Ulf Andréasson, Oskar Hansson, et al.. (2008). Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease. Archives of Neurology. 65(8). 1102–7. 182 indexed citations
7.
Buchhave, Peder, Sabina Janciauskiene, Henrik Zetterberg, et al.. (2008). Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease. Neuroscience Letters. 450(1). 56–59. 32 indexed citations
8.
Buchhave, Peder, Henrik Zetterberg, Kaj Blennow, et al.. (2008). Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiology of Aging. 31(11). 1877–1884. 98 indexed citations
9.
Höglund, Kina, Oskar Hansson, Peder Buchhave, et al.. (2008). Prediction of Alzheimer’s Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides. Neurodegenerative Diseases. 5(5). 268–276. 29 indexed citations
10.
Hansson, Oskar, Henrik Zetterberg, Peder Buchhave, et al.. (2007). Prediction of Alzheimer’s Disease Using the CSF Aβ42/Aβ40 Ratio in Patients with Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. 23(5). 316–320. 240 indexed citations
11.
Hansson, Oskar, Peder Buchhave, Henrik Zetterberg, et al.. (2007). Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease. Neurobiology of Aging. 30(2). 165–173. 64 indexed citations
12.
Hansson, Oskar, Henrik Zetterberg, Peder Buchhave, et al.. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. The Lancet Neurology. 5(3). 228–234. 1261 indexed citations breakdown →
13.
Andolf, Ellika, et al.. (1995). Fluid characteristics of benign ovarian cysts: correlation with recurrence after puncture. Obstetrics and Gynecology. 86(4). 529–535. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiyun Chai Breakdown of academic impact, for papers by Udo Eichenlaub Breakdown of academic impact, for papers by Tobias Bittner Breakdown of academic impact, for papers by Andréa Lessa Benedet Breakdown of academic impact, for papers by Ronald S. Black Breakdown of academic impact, for papers by Niki S.M. Schoonenboom Breakdown of academic impact, for papers by M Orantes Breakdown of academic impact, for papers by Tero Tapiola Breakdown of academic impact, for papers by Daniel J. Kerkman Breakdown of academic impact, for papers by Vitaliy Ovod
Rankless by CCL
2026